Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2

VIRUSES-BASEL

MDPI

1. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Centers of Excellence for Influenza Research and Response (CEIRR) [75N93021C00016]
2. This work was funded, in whole or in part, by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Collaborative Influenza Vaccine Innovation Centers (CIVICs) [75N93019C00052]
3. St. Jude Children's Research Hospital
4. American Lebanese Syrian Associated Charities (ALSAC)